Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.52 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.52 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.48 |
| ▸ | MAPT | P10636 | 8/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11635247 | 0.98 | MAPK1 (0.50) | MAPK1HDAC3ADRA1AHDAC4SLC6A3 | |
| SCHEMBL9705770 | 0.94 | MAPT (0.52) | MAPK1HDAC3ADRA1AHDAC4SLC6A3 | |
| SCHEMBL11912385 | 0.93 | MAPT (0.55) | MAPK1HDAC3ADRA1AHDAC4SLC6A3 | |
| SCHEMBL11460690 | 0.93 | MAPT (0.55) | MAPK1HDAC3ADRA1AHDAC4SLC6A3 | |
| SCHEMBL8091454 | 0.93 | MAPT (0.55) | MAPK1HDAC3ADRA1AHDAC4SLC6A3 | |
| SCHEMBL8093637 | 0.93 | MAPT (0.55) | MAPK1HDAC3ADRA1AHDAC4SLC6A3 | |
| SCHEMBL16124206 | 0.93 | MAPT (0.55) | MAPK1HDAC3ADRA1AHDAC4SLC6A3 | |
| SCHEMBL11722021 | 0.93 | MAPT (0.55) | MAPK1HDAC3ADRA1AHDAC4SLC6A3 | |
| SCHEMBL236223 | 0.88 | ALDH1A1 (0.54) | MAPK1ALDH1A1MAPTKDM4EHSD17B10 | |
| Hydrochloric Acid SCHEMBL27401794 | 0.86 | ALDH1A1 (0.52) | MAPK1ALDH1A1MAPTKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114563491-B | Method for monitoring sample quality change in donkey-hide gelatin processing technology | 山东师范大学 | 2024-08-20 | — | — | CN | claimed |
| CN-109789600-B | Aerosol container made of plastic | 阿尔温莱纳股份有限两合公司阿尔普拉工厂 | 2021-09-28 | — | — | CN | claimed |
| EP-0790974-B1 | SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS | BAYER AG (US) | 2002-08-14 | — | — | EP | claimed |
| US-4609739-A | Synthetic routes to benzofurans and benzothiophenes and intermediates therefor | THE UPJOHN COMPANY (US) | 1986-09-02 | — | — | US | claimed |
| EP-4593888-A1 | CROSSLINKED RADIOPAQUE NETWORKS FOR MEDICAL APPLICATIONS | Boston Scientific Scimed Inc. (US) | 2025-08-06 | — | — | EP | disclosed |
| CN-119947762-A | Crosslinked radiopaque networks for medical applications | 波士顿科学医学有限公司 | 2025-05-06 | — | — | CN | disclosed |
| US-20240123095-A1 | CROSSLINKED RADIOPAQUE NETWORKS FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-04-18 | — | — | US | disclosed |
| WO-2024073271-A1 | CROSSLINKED RADIOPAQUE NETWORKS FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| CN-117741006-A | In-situ identification method for laser printing file species | 山东政法学院 | 2024-03-22 | — | — | CN | disclosed |
| CN-109789600-B | Aerosol container made of plastic | 阿尔温莱纳股份有限两合公司阿尔普拉工厂 | 2021-09-28 | — | — | CN | disclosed |
| EP-3769776-A1 | PEPTIDOMIMETIC MACROCYCLES | Aileron Therapeutics, Inc. (US) | 2021-01-27 | — | — | EP | disclosed |
| US-20200216836-A1 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION A/S (DK) | 2020-07-09 | — | — | US | disclosed |
| US-5854277-A | Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors | BAYER CORPORATION (US) | 1998-12-29 | — | — | US | disclosed |
| US-5789434-A | ACID, ESTER OR AMIDE DERIVATIVES AS ANTIINFLAMMATORY AGENTS, ANTIARTHRITIC AGENTS AND REDUCTION OF CARTILAGE DETERIORATION | BAYER CORPORATION (US) | 1998-08-04 | — | — | US | disclosed |
| EP-0790974-A1 | SUBSTITUTED 4-BIARYLBUTYRIC OR 5-BIARYLPENTANOIC ACIDS AND DERIVATIVES AS MATRIX METALLOPROTEASE INHIBITIORS | Bayer Corporation (US) | 1997-08-27 | — | — | EP | disclosed |
| US-4609739-A | Synthetic routes to benzofurans and benzothiophenes and intermediates therefor | THE UPJOHN COMPANY (US) | 1986-09-02 | — | — | US | disclosed |
| US-4097485-A | HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1978-06-27 | — | — | US | disclosed |
| US-4093622-A | Pyridine esters of cyclopropane-carboxylic acid | ZOECON CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |
| US-4086241-A | Benzothiazolylimidazolidinone esters of furyl and thienyl substituted acids | VELSICOL CHEMICAL CORPORATION (US) | 1978-04-25 | — | — | US | disclosed |
| US-4061648-A | HERBICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1977-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240123095-A1 | CROSSLINKED RADIOPAQUE NETWORKS FOR MEDICAL APPLICATIONS | PAICS, RAD54L, RAD18 | MAPK1 3336/4885HDAC3 3661/4885ADRA1A 464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.